The House Energy & Commerce health subcommittee will hold a hearing next Tuesday (March 28) on reauthorization of the Medical Device User Fee Amendments (MDUFA), marking the committee's third user fee hearing. The panel held a hearing March 2 on reauthorization of the generic and biosimilar user fee agreements, and will hold a hearing Wednesday (March 22) on the Prescription Drug User Fee Act. “Both FDASIA and the 21st Century Cures Act included numerous provisions improving the device development and...